Literature DB >> 32073418

Ischemia in patients with no obstructive coronary artery disease: classification, diagnosis and treatment of coronary microvascular dysfunction.

Vincenzo Sucato1, Giuseppina Novo, Antonino Saladino, Marianna Rubino, Nicola Caronna, Mirko Luparelli, Alessandro D'Agostino, Salvatore Novo, Salvatore Evola, Alfredo Ruggero Galassi.   

Abstract

Patients with coronary microvascular dysfunction represent a widespread population, and despite the good prognosis, many of them, because of the angina symptoms, have a poor quality of life with strong limitations in their daily activities. In 2017, a new classification of microvascular dysfunction as well as a new definition of ischemia in patients with no obstructive coronary artery disease became available. This new definition improves Kemp's initial work, where cardiac X syndrome was initially described. This work summarizes the last updates on the subject with particular attention to the new classification of microvascular dysfunction, with particular attention to microvascular and vasospastic angina definition and diagnostic criteria.

Entities:  

Mesh:

Year:  2020        PMID: 32073418     DOI: 10.1097/MCA.0000000000000855

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  5 in total

Review 1.  The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective.

Authors:  Houyong Zhu; Hanxin Wang; Xinyu Zhu; Qilan Chen; Xiaojiang Fang; Xiaoqun Xu; Yan Ping; Beibei Gao; Guoxin Tong; Yu Ding; Tielong Chen; Jinyu Huang
Journal:  Adv Ther       Date:  2022-10-24       Impact factor: 4.070

2.  Classification, Diagnosis, and Treatment of Coronary Microvascular Dysfunction.

Authors:  Vincenzo Sucato; Cristina Madaudo; Alfredo Ruggero Galassi
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

3.  Prognostic impact of coronary microvascular dysfunction assessed by caIMR in overweight with chronic coronary syndrome patients.

Authors:  Cailin Feng; Fuad A Abdu; Abdul-Quddus Mohammed; Wen Zhang; Lu Liu; Guoqing Yin; Yundi Feng; Ayman A Mohammed; Redhwan M Mareai; Xian Lv; Tingting Shi; Yawei Xu; Xuejing Yu; Wenliang Che
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-10       Impact factor: 6.055

4.  Myocardial infarction with non-obstructive coronary arteries in a patient double-seropositive for anti-glomerular basement membrane and anti-neutrophil cytoplasmic antibodies: A case report.

Authors:  Marcell Krall; Johannes Gollmer; Marion J Pollheimer; Clemens Reiter; Michael Kolland; Alexander H Kirsch; Andreas Kronbichler; Kathrin Eller; Alexander R Rosenkranz; Balazs Odler
Journal:  Front Cardiovasc Med       Date:  2022-09-23

5.  In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes.

Authors:  Shaowei Wang; Mikalai Budzevich; Mahmoud A Abdalah; Yoganand Balagurunathan; Jung W Choi
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.